- Researcher in the Unit for Psychiatric Research at Aalborg Psychiatric Hospital
- Not Clearly Pro or Con to the question "Should Marijuana Be a Medical Option?"
“The risk of schizophrenia after a cannabis-induced psychosis is independent of familial predisposition… Cannabis-induced psychosis may be an early marker of schizophrenia… Psychotic symptoms after cannabis use should be taken extremely seriously.”
“Familial Predisposition for Psychiatric Disorder: Comparison of Subjects Treated for Cannabis-Induced Psychosis and Schizophrenia,” Archives of General Psychiatry, 2008
- Theoretical Expertise Ranking:
Individuals with MDs, PhDs, JDs, or equivalent advanced degrees in fields relevant to medical marijuana. Also top-level government officials (such as foreign leaders, US presidents, Founding Fathers, Supreme Court Justices, members of legislative bodies, cabinet members, military leaders, etc.) with positions relevant to medical marijuana issues.
- Involvement and Affiliations:
- Researcher, Unit for Psychiatric Research, Aalborg Psychiatric Hospital, Aarhus University Hospital (Denmark)
- Member, European Psychiatric Association, 2011
- Lecturer, “Cannabis and Psychosis,” Aalborg Psychiatric Summer School, 2010
- Visiting Researcher, Columbia University, 2006 and 2009
- Lecturer, “Cannabis Use and Psychotic Symptoms,” Aalborg Psychiatric Hospital, 2008
- PhD, Health Sciences, University of Aarhus, 2006
- MSCPsych, Psychology, University of Aarhus, 2001
- Dr. Arendt’s research is primarily focused on the relationship between cannabis use and psychiatric disorders, but he has also published original research on PTSD, panic disorder, depression, bipolar disorder, and schizophrenia.